Gilead Sciences Inc. (GILD34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
338. 65
-2.59
-0.759%
R$
850.15B Market Cap
17.2 P/E Ratio
0.42% Div Yield
217 Volume
6.22 Eps
R$ 341.24
Previous Close Want to track GILD34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming GILD34 split of 6:1 in 7 days (17 Aug 2026)
Gilead Sciences Inc. (GILD34) Statistics
Valuation metrics
Market Cap 850.15B
Enterprise value 2.05T
Trailing P/E (ttm) 18.94
Forward P/E -
PEG ratio 0.82
Price/Sales (ttm) 27.07
Price/Book (mrq) 3.51
Enterprise Value/Revenue 14.07
Enterprise Value/EBITDA 28.43
Overview
Shares outstanding 1.24B
Float 1.24B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 55
Average volume (90 days) 19
Price summary
52-Week low 293.85
52-Week high 396.35
Beta 0.4
50-Day moving average 362.79
200-Day moving average 338.39
Dividends and splits
Forward annual dividend rate 5.99
Forward annual dividend yield 0.0187%
Trailing annual dividend rate 5.98
Trailing annual dividend yield 0.0186%
5-Year annual dividend yield 3.27%
Payout ratio 0.32
Dividend Date 3 Jul 2026
Ex-Dividend Date 11 Jun 2026
Last split factor 6:1
Last split Date 30 Jul 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.29%
Operating margin 0.37%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.41%
Income Statement
Revenue (ttm) 145.93B
Revenue per share (ttm) 23.67
Quarterly revenue growth (yoy) 0.05%
Gross profit (ttm) 115.05B
EBITDA 14.81B
Net income to common (ttm) 42.18B
Diluted EPS (ttm) 16.95
Quarterly earnings growth (yoy) 0.22%
Balance Sheet
Total cash (mrq) 47.65B
Total cash per share (mrq) 7.74
Total debt (mrq) 126.59B
Total Debt/Equity (mrq) 112.92
Current ratio (mrq) 1.55%
Book value per share (mrq) 91.38
Cash Flow
Cash flow statement 49.66B
Levered free cash flow (LFCF) 37.37B
